In the rapidly evolving field of cancer immunotherapy, immune checkpoint antibodies have emerged as powerful tools to modulate the immune system's response to tumors. These specialized antibodies target immune checkpoint pathways—regulatory mechanisms that normally maintain immune homeostasis but are often hijacked by cancer cells to evade immune detection. From their...
Among malignant tumors affecting women, breast cancer consistently ranks first in incidence. Approximately 70% of cases are hormone receptor (HR)–positive and human epidermal growth factor receptor 2 (HER2)–negative. Endocrine therapy is the cornerstone of treatment for this subtype; however, patients with advanced disease frequently develop resistance, leading to a major...
Adenoid cystic carcinoma (ACC) might not be a term you hear every day, but if you or a loved one has been diagnosed, it can feel overwhelming. So, what is adenoid cystic carcinoma? Simply put, it’s a rare type of cancer that most often affects the salivary glands but can appear in other parts of the body, too.
In this article, we’ll break...
Generic Anti-cancer Injectables Market size was estimated at USD 106.60 billion in 2025 and is expected to attain around USD 456.61 billion by 2032, growing at a CAGR of 12.09% from 2025-2032.
The Generic Anti-cancer Injectables Market research report has been crafted with the most advanced and best tools to collect, record, estimate, and analyze market data. The report also sheds light...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek